INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR
Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 64 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG shows excellent growth, but is valued quite expensive already. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
1ISRG had positive earnings in the past year.
In the past year 1ISRG had a positive cash flow from operations.
Each year in the past 5 years 1ISRG has been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 12.88%, 1ISRG belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
1ISRG has a Return On Equity of 14.47%. This is in the better half of the industry: 1ISRG outperforms 79.69% of its industry peers.
The Return On Invested Capital of 1ISRG (10.45%) is better than 81.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.65%.
The last Return On Invested Capital (10.45%) for 1ISRG is above the 3 year average (10.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROIC | 10.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1.3 Margins
With an excellent Profit Margin value of 28.41%, 1ISRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
1ISRG's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.28%, 1ISRG belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ISRG has declined.
The Gross Margin of 1ISRG (67.09%) is better than 67.19% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 58.66 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1ISRG (58.66) is better than 100.00% of its industry peers.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 58.66 |
ROIC/WACC1.15
WACC9.11%
2.3 Liquidity
1ISRG has a Current Ratio of 4.98. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.98, 1ISRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
A Quick Ratio of 3.97 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a Quick ratio of 3.97. This is amongst the best in the industry. 1ISRG outperforms 95.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 27.76% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
1ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.08%.
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
3.2 Future
1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.45% yearly.
Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 68.35 indicates a quite expensive valuation of 1ISRG.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
The average S&P500 Price/Earnings ratio is at 26.55. 1ISRG is valued rather expensively when compared to this.
1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 56.56.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than 64.06% of the companies in the same industry.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.40, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.35 | ||
| Fwd PE | 56.56 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 65.63% of the companies in the same industry.
1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 107.16 | ||
| EV/EBITDA | 64.66 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1ISRG may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 13.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.73
PEG (5Y)5.95
EPS Next 2Y12.18%
EPS Next 3Y13.88%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (6/11/2025, 7:00:00 PM)
456.55
-32.7 (-6.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap163.64B
Analysts79.49
Price Target526.29 (15.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)2.47%
PT rev (3m)-15.2%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.35 | ||
| Fwd PE | 56.56 | ||
| P/S | 21.46 | ||
| P/FCF | 107.16 | ||
| P/OCF | 68.48 | ||
| P/B | 10.93 | ||
| P/tB | 11.17 | ||
| EV/EBITDA | 64.66 |
EPS(TTM)6.68
EY1.46%
EPS(NY)8.07
Fwd EY1.77%
FCF(TTM)4.26
FCFY0.93%
OCF(TTM)6.67
OCFY1.46%
SpS21.27
BVpS41.76
TBVpS40.86
PEG (NY)7.73
PEG (5Y)5.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROCE | 13.94% | ||
| ROIC | 10.45% | ||
| ROICexc | 14.17% | ||
| ROICexgc | 14.58% | ||
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% | ||
| FCFM | 20.03% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 185.49% | ||
| Cap/Sales | 11.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.16% | ||
| Profit Quality | 70.49% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 | ||
| Altman-Z | 58.66 |
F-Score6
WACC9.11%
ROIC/WACC1.15
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%